Aim: Dominant negative mutations of the inwardly rectifying K + channel Kir2.1 cause Andersen-Tawil syndrome, an autosomal dominant disorder. Here, we identified a novel Kir2.1 mutation causing autosomal recessive ATS, and explored the underlying mechanism.
Autosomal recessive ATS, 5 3′); and primer4-forward (5′-ACGGACACGCCCCCTGACAT-3′) and reverse (5′AGTCCCTTGTGGCCGCTTGC-3′). PCR was performed with LA Taq DNA polymerase (TAKARA, Shiga, Japan) on a thermal cycler (ASTEC, Fukuoka, Japan).
The PCR products were purified using a PCR Product Purification kit (Medical & Biological Laboratories Co., Aichi, Japan). The products were sequenced in both directions and resolved using an ABI PRISM 310 Genetic Analyzer (Applied Biosystems, Foster City, CA). CytoScan HD Solution (Affymetrix, Snta Clara, CA) was used for DNA copy number and areas of loss of heterozygosity. The results was analysis by the Affymetrix Chromosome Analysis Suite (ChAS) software. Percentage of homozygosity was calculated by summing ROH > 5 Mb across the covered autosome ( 2,578,427,245 bps for CytoScan) as previously described. 12 The mutation has been submitted to a database based on the Leiden Open Variation Database and accessible at www.lovd.nl/kcnj2. Lipophilicity of the transmembrane region was calculated using the empirical scoring function LIPS (LIPid-facing Surface) (http://tanto.bioengr.uic.edu/lips/).
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Expression of KCNJ2
PCR was performed with Pfu Ultra High Fidelity DNA polymerase (Agilent Technologies, Santa Clara, CA). Wild-type (WT) and mutant (L94P) PCR products were digested with EcoR I and Sal I and were subcloned into pEGFP-N3 (Clontech, Mountain View, CA) or digested with BamH I and Xho I and subcloned into pcDNA3
(Life Technologies, Carlsbad, CA). The complete KCNJ2 coding region was sequenced in all constructs for verification. 
Immunostaining and microscopy
Immunocytochemistry for membrane inositol lipids was performed as previously described. 14 Twenty-four hours after transfection, the cells were chilled for 2 minutes then fixed with 4% paraformaldehyde and 0.2% glutaraldehyde for 15 minutes.
The cells were blocked and permeabilized with 10% goat serum and 0.5% saponin for 45 minutes on ice. Then, the cells were incubated with mouse anti-PIP2 antibody (2C11, Technologies). To minimize the cell surface, CHO-K1 cells transfected with Kir2.1EGFP were observed on coverslips after being stripped from the dishes by treatment with 0.25% trypsin for 30 s and resuspended in phosphate-buffered saline (PBS). 15 The cells were examined by confocal laser scanning microscopy (Olympus, Tokyo, Japan) with a 60× oil immersion objective lens.
Plasma membrane sheet assay
The plasma membrane sheet assay was used to obtain plasma membrane lawns. 16 
Statistical analysis
Comparisons were made using analysis of variance and Dunnett's test. Values of p < 0.05 were considered significant. All values are reported as mean ± standard error.
Results
Identification of KCNJ2 mutation in a family
A novel mutation c.281T>C was identified in the proband (II-3) and the proband's mother (I-2) ( Fig. 1B and C) . The mutation, which would substitute leucine for proline (p.Leu94Pro), was located in an -helix that forms the outer transmembrane region M1 (Fig. 1D ). Leucine at residue 94 is highly conserved across species (Fig. 1E) and is one of the nine lipid-facing residues located in helix M1. 17 Leucine is a hydrophobic amino acid that is important for protein-bilayer interactions and membrane protein folding. The average helical-face lipophilicity score for WT M1 was 3.182, whereas that for L94P was 2.989, which is smaller than that for another helical- 
Subcellular distribution
Confocal microscopy imaging was performed to investigate the channel distribution in HEK293 cells. We examined the localization of Kir2.1 in relation to that of PIP2 that interacts with Kir2.1 at plasma membranes. WT-EGFP was expressed at the plasma membrane and colocalized with PIP2 (Fig. 3A) . In contrast, L94P-EGFP was only faintly expressed at the plasma membrane, and was mainly localized in the cytoplasm (Fig. 3A) . The cell surface expression of L94P-EGFP channel proteins was
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increased by co-expression with WT (Fig. 3A) . To clarify the subcellular transport of Kir2.1, we examined the localization of EGFP in HEK293 cells that had been stripped from the dishes (Fig. 3B) . The line intensity histograms showed that WT-EGFP and L94P-EGFP co-transfected with pcDNA3-WT gave strong signals at the plasma membrane. However, L94P-EGFP signals alone were weak at the plasma membrane.
We then used a plasma membrane sheet assay to evaluate the expression levels of the Kir channel at the plasma membrane. Proteins extracted from HEK293 cells transfected with WT-EGFP, L94P-EGFP, or L94P-EGFP+WT-EGFP were analyzed using an antiGFP antibody. The assay detected less L94P-EGFP protein than WT-EGFP or L94PEGFP+WT-EGFP proteins at the plasma membrane (Fig. 3C) . These results suggest that WT subunits can form heterotetramers with L94P subunits and be recruited to the plasma membrane.
Electrophysiological analysis
Finally, we investigated the effects of the L94P mutation on the properties of the Kir2.1 channel. CHO-K1 cells were transfected with WT-EGFP (2 μg), L94P-EGFP (2 μg), or L94P-EGFP (1 μg) +pcDNA3-WT (1 μg). Inwardly rectifying currents that reversed around the equilibrium potential of K + could be recorded from cells expressing WT-EGFP (Fig. 4A) , as reported previously. 18 In contrast, the currents were significantly weaker in the cells expressing L94P-EGFP (-332.9 ± 47.9 pA) than in those expressing WT-EGFP (-2217.4 ± 337.4 pA at hp = -150 mV; p < 0.001) (Fig. 4A, B) . This result may be consistent with our evidence indicating reduced translocation of mutant Kir2.1 to the plasma membrane (Fig. 3A) . Inwardly-rectifying currents were observed in cells co-expressing both L94P-EGFP and WT. The current amplitude in these cells (-1482.6 ± 304.1 pA at hp = -150 mV) was about 67% of that in cells expressing WT-EGFP (Fig.   4A ), but the difference was not significant (p = 0.099) (Fig. 4B) . These results suggest that the L94P mutation does not have a severe dominant negative effect on the WT protein.
Discussion
We identified a novel Kir2.1 L94P mutation in a patient with ATS that reduced protein trafficking to the plasma membrane. The large regions of homozygosity on the autosome suggest parental consanguinity and autosomal recessive inheritance.
Kir2.1 channel has outer and inner transmembrane helix domains called M1 and M2,
respectively, and the N-terminus and C-terminus form the cytoplasmic domains. The PIP2-binding residues of Kir2.1 located in the cytoplasmic domain are the most common targets for mutation. 5 PIP2 binding with the cytoplasmic domain induces a conformational change that induces channel opening. 19 The L94 residue in the M1 segment faces the lipid bilayer 17 and does not communicate with PIP2. Increasing lines of evidence indicate that trafficking-defective mutant proteins (Δ95-98, C101R, Δ314-315, and S369X) are incapable of reaching the plasma membrane by themselves. 2, 3, 7 Because the C-terminus of Kir2.1 is necessary to promote the export from the ER 20 and/or the Golgi apparatus, 21, 22 lack of export motifs in C-terminus induced by Δ314-315 and S369X causes trafficking defect. Δ95-98 and C101R are located in M1, like L94P. The Δ95-98 protein is trapped in the cytoplasm even when it is co-transfected with WT protein. C101R is also indicated to be a trafficking-defective mutation.
Δ95-98 causes misfolding of the protein and retention in the ER or degradation, L94P
may have the ability to co-localize with the WT protein in the plasma membrane.
S369X mutant protein co-transfected with WT could be transported to the membrane and form functional channels. 7 L94P is similar to S369X in that these mutants do not exhibit dominant negative effects on the WT protein.
The L94 residue faces the lipid bilayer. 17 The Kir channel transmembrane helix structures are based on the prokaryotic homologs of Kir channels KirBac structure, because they all have two transmembrane helix domains. The mutation of G77 in Kir4.1 (G77R) that corresponds to L94 in Kir2.1 17 shows a reduction of surface expression in vitro and an autosomal recessive pattern in inheritance 23 as does L94P. The authors suggested that the replacement of glycine with arginine in this mutation would be unfavorable in the lipid bilayer. Leucine has a large side chain and is strongly hydrophobic; conversely, proline has a small non-polar side chain and is weakly hydrophobic. High lipophilicity of the lipid-facing region in a transmembrane helix is required to retain it in the lipid bilayer. 24 Replacement of a leucine with a proline is predicted to change the lipophilicity and may disrupt protein stability in the plasma membrane. Upon delivery to the plasma membrane, the L94P/WT heterotetramer could elicit an inward current. These characteristics might be associated with autosomal recessive inheritance.
Hereditary variation in channelopathies is also reported for the voltage-gated chloride channel. Myotonia congenita, caused by chloride channel gene mutations, expresses as autosomal dominant myotonia congenita (Thomsen's disease) or autosomal
Autosomal recessive ATS, 13 recessive myotonia congenita (Becker's disease). In dominant myotonia congenita, one well-accepted mechanism is that mutations located at or near the heterodimer interface of the chloride channel cause a dominant negative effect on the function of the gate. 25, 26 Conversely, the recessive form of myotonia congenita is diverse in its mechanisms. Among these, a recent report demonstrated two mutations related to trafficking defects. 27 Both mutations were situated in a membrane-spanning segment of the transmembrane region. One of the mutant channels was functional when delivered to the plasma membrane.
Kir2.1 is expressed not only in excitable cells such as neurons, skeletal muscle, and cardiac muscle but also in endothelial cells. In endothelial cells, Kir2.1 is required for the response to shear stress. 28 In our proband, flow-mediated vasodilation was reduced but nitroglycerine-mediated vasodilation was preserved, indicative of an impairment of endothelial-dependent vasodilatation probably caused by poor sensitivity to shear stress, at least in part. In addition, a recent study has suggested that a mutation in the Drosophila homolog of Kir2.1 disrupts the function of bone morphogenetic protein (BMP), part of the transforming growth factor β (TGFβ)/BMP signaling pathway, and causes morphological abnormalities similar to ATS. 29 Because TGFβ/BMP signaling also controls vascular morphogenesis and extracellular matrix synthesis, 30 patients with Loeys-Dietz syndrome, caused by impairment of TGFβ/BMP signaling, have a risk of aortic dissection. The L94P mutation in Kir2.1 might be a cause of the asymptomatic carotid artery dissection in this proband via disruption of TGFβ/BMP signaling.
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In summary, the Kir2.1 mutation L94P shows a reduction of surface expression in vitro and an autosomal recessive pattern in inheritance. These findings provide insight into the molecular mechanisms underlying different modes of inheritance of a human clinical condition of the nervous system. Moreover, our methods and hypotheses may be applicable to the study of other channelopathies. 
